Prescribed Opioid Use in Wisconsin 2008-2016: Findings From the Survey of the Health of Wisconsin.
Journal
WMJ : official publication of the State Medical Society of Wisconsin
ISSN: 2379-3961
Titre abrégé: WMJ
Pays: United States
ID NLM: 9716054
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
entrez:
14
7
2020
pubmed:
14
7
2020
medline:
13
7
2021
Statut:
ppublish
Résumé
The opioid epidemic is a national crisis. The objectives of this report were to describe prescription opioid use in Wisconsin from 2008 through 2016 using unique populationrepresentative data and to assess which demographic, health, and behavioral health characteristics were related to past 30-day prescribed opioid use. Data were obtained from the Survey of the Health of Wisconsin (SHOW), a statewide representative sample of 4,487 adults. Prescription medication use was ascertained via in-person interviews that included an inventory of all prescription medications used by the respondent in the past 30 days. The data were weighted to represent the adult population of Wisconsin, aged 21 to 74. Chi-square, logistic regression, and descriptive statistics were used to analyze data. From 2008 to 2016, 6.4% (95% CI, 5.5-7.3) of adults age 21 years or older reported using a prescribed opioid in the past 30 days. Hydrocodone was the most prescribed opioid class followed by oxycodone. People 50 years of age and older, self-identified black or Hispanic, urban dwellers, those with a high school education or less, and those having incomes below 200% of the federal poverty level (FPL) reported significantly higher rates of prescribed opioid use relative to others. Participants reporting physician-diagnosed drug or alcohol abuse, current smokers, and those currently suffering from depression also reported significantly higher use. These data from 2008-2016 demonstrate concerning levels of prescription opioid use and provide data on which population groups may be most vulnerable. While policies and clinical practice have changed since 2016, ongoing evaluation of prescribing practices, including consideration of behavioral health issues when prescribing opioids, is called for.
Sections du résumé
BACKGROUND
BACKGROUND
The opioid epidemic is a national crisis. The objectives of this report were to describe prescription opioid use in Wisconsin from 2008 through 2016 using unique populationrepresentative data and to assess which demographic, health, and behavioral health characteristics were related to past 30-day prescribed opioid use.
METHODS
METHODS
Data were obtained from the Survey of the Health of Wisconsin (SHOW), a statewide representative sample of 4,487 adults. Prescription medication use was ascertained via in-person interviews that included an inventory of all prescription medications used by the respondent in the past 30 days. The data were weighted to represent the adult population of Wisconsin, aged 21 to 74. Chi-square, logistic regression, and descriptive statistics were used to analyze data.
RESULTS
RESULTS
From 2008 to 2016, 6.4% (95% CI, 5.5-7.3) of adults age 21 years or older reported using a prescribed opioid in the past 30 days. Hydrocodone was the most prescribed opioid class followed by oxycodone. People 50 years of age and older, self-identified black or Hispanic, urban dwellers, those with a high school education or less, and those having incomes below 200% of the federal poverty level (FPL) reported significantly higher rates of prescribed opioid use relative to others. Participants reporting physician-diagnosed drug or alcohol abuse, current smokers, and those currently suffering from depression also reported significantly higher use.
CONCLUSION
CONCLUSIONS
These data from 2008-2016 demonstrate concerning levels of prescription opioid use and provide data on which population groups may be most vulnerable. While policies and clinical practice have changed since 2016, ongoing evaluation of prescribing practices, including consideration of behavioral health issues when prescribing opioids, is called for.
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102-109Subventions
Organisme : NHLBI NIH HHS
ID : RC2 HL101468
Pays : United States
Organisme : NCIPC CDC HHS
ID : U17 CE002741
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR025011
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002373
Pays : United States
Informations de copyright
Copyright© Board of Regents of the University of Wisconsin System and The Medical College of Wisconsin, Inc.
Références
Ann Emerg Med. 2015 Sep;66(3):246-252.e1
pubmed: 25865093
Patient Educ Couns. 2015 Apr;98(4):453-61
pubmed: 25601279
Adv Alcohol Subst Abuse. 1984 Summer;3(4):35-46
pubmed: 6391108
J Am Med Inform Assoc. 2011 Jul-Aug;18(4):441-8
pubmed: 21515544
BMC Public Health. 2010 Dec 23;10:785
pubmed: 21182792
Pain. 2012 May;153(5):967-73
pubmed: 22386895
Acta Anaesthesiol Scand. 2014 Apr;58(4):437-45
pubmed: 24593770
J Adolesc Health. 2013 Apr;52(4):480-5
pubmed: 23298996
CMAJ. 2017 Jan 9;189(1):E42-E43
pubmed: 27873758
J Pain. 2010 Jan;11(1):44-52
pubmed: 19628436
Clin J Pain. 2018 Sep;34(9):878-884
pubmed: 29505419
Subst Use Misuse. 2018 Jan 28;53(2):290-300
pubmed: 28854060
Ann Emerg Med. 2000 Jan;35(1):11-6
pubmed: 10613935
Clin Obstet Gynecol. 2019 Mar;62(1):98-109
pubmed: 30601171
Pain. 2008 Sep 15;138(3):507-13
pubmed: 18342447
Eur J Pain. 2014 Jul;18(6):835-43
pubmed: 24921073
Pharmacoepidemiol Drug Saf. 2016 May;25(5):539-44
pubmed: 26660909
Demography. 2017 Jun;54(3):1175-1202
pubmed: 28324483
PLoS One. 2016 Aug 08;11(8):e0159224
pubmed: 27501459
Drug Alcohol Depend. 2015 Apr 1;149:117-21
pubmed: 25678441
Ann Surg. 2017 Apr;265(4):709-714
pubmed: 27631771